↓ Skip to main content

Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids

Overview of attention for article published in The Journal of Experimental Medicine, January 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
7 news outlets
blogs
1 blog
twitter
4 X users
patent
7 patents

Readers on

mendeley
278 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids
Published in
The Journal of Experimental Medicine, January 2014
DOI 10.1084/jem.20130301
Pubmed ID
Authors
Abstract

IL-17A-expressing CD4(+) T cells (Th17 cells) are generally regarded as key effectors of autoimmune inflammation. However, not all Th17 cells are pro-inflammatory. Pathogenic Th17 cells that induce autoimmunity in mice are distinguished from nonpathogenic Th17 cells by a unique transcriptional signature, including high Il23r expression, and these cells require Il23r for their inflammatory function. In contrast, defining features of human pro-inflammatory Th17 cells are unknown. We show that pro-inflammatory human Th17 cells are restricted to a subset of CCR6(+)CXCR3(hi)CCR4(lo)CCR10(-)CD161(+) cells that transiently express c-Kit and stably express P-glycoprotein (P-gp)/multi-drug resistance type 1 (MDR1). In contrast to MDR1(-) Th1 or Th17 cells, MDR1(+) Th17 cells produce both Th17 (IL-17A, IL-17F, and IL-22) and Th1 (IFN-γ) cytokines upon TCR stimulation and do not express IL-10 or other anti-inflammatory molecules. These cells also display a transcriptional signature akin to pathogenic mouse Th17 cells and show heightened functional responses to IL-23 stimulation. In vivo, MDR1(+) Th17 cells are enriched and activated in the gut of Crohn's disease patients. Furthermore, MDR1(+) Th17 cells are refractory to several glucocorticoids used to treat clinical autoimmune disease. Thus, MDR1(+) Th17 cells may be important mediators of chronic inflammation, particularly in clinical settings of steroid resistant inflammatory disease.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 278 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 2 <1%
Japan 1 <1%
Denmark 1 <1%
Germany 1 <1%
Brazil 1 <1%
Austria 1 <1%
Unknown 271 97%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 73 26%
Student > Ph. D. Student 53 19%
Student > Doctoral Student 20 7%
Student > Bachelor 18 6%
Student > Master 17 6%
Other 51 18%
Unknown 46 17%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 68 24%
Medicine and Dentistry 64 23%
Immunology and Microbiology 45 16%
Biochemistry, Genetics and Molecular Biology 26 9%
Neuroscience 4 1%
Other 15 5%
Unknown 56 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 67. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 September 2026.
All research outputs
#804,256
of 34,447,360 outputs
Outputs from The Journal of Experimental Medicine
#416
of 13,372 outputs
Outputs of similar age
#6,983
of 372,753 outputs
Outputs of similar age from The Journal of Experimental Medicine
#3
of 42 outputs
Altmetric has tracked 34,447,360 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,372 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.3. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 372,753 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.